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1Mono and dinuclear arene ruthenium complexes containing
6,7-dimethyl-2,3-di(pyridine-2-yl)quinoxaline as chelating ligand:
Synthesis and molecular structure
Bruno Therrien *, Georg Su¨ss-Fink, Padavattan Govindaswamy, Cynthia Sa€ıd-Mohamed
Institut de Chimie, Universite´ de Neuchaˆtel, Case Postale 158, CH-2009 Neuchaˆtel, SwitzerlandAbstract
The mononuclear cations of the general formula [(g6-arene)RuCl(dpqMe2)]
+ (dpqMe2 = 6,7-dimethyl-2,3-di(pyridine-2-yl)quinoxa-
line; arene = C6H6, 1; C6H5Me, 2; p-Pr
iC6H4Me, 3; C6Me6, 4) as well as the dinuclear dications [(g
6-arene)2Ru2Cl2(l-dpqMe2)]
2+
(arene = C6H6, 5; C6H5Me, 6; p-Pr
iC6H4Me, 7; C6Me6, 8) have been synthesised from 6,7-dimethyl-2,3-di(pyridine-2-yl)quinoxaline
(dpqMe2) and the corresponding chloro complexes [(g
6-C6H6)Ru(l-Cl)Cl]2, [(g
6-C6H5Me)Ru(l-Cl)Cl]2, [(g
6-p-PriC6H4Me)Ru(l-Cl)Cl]2
and [(g6-C6Me6)Ru(l-Cl)Cl]2, respectively. The X-ray crystal structure analyses of [1][PF6], [3][PF6] and [6][PF6]2 reveal a typical piano-
stool geometry around the metal centre; in the dinuclear complexes the two chloro ligands, with respect to each other, are found to be
trans oriented.
Keywords: Arene ligands; Dinuclear complexes; N ligands; Ruthenium; Transfer hydrogenation1. Introduction
Polypyridyl complexes of ruthenium have received
considerable attention owing to their photochemical
properties [1], catalytic activities [2], electrochemical
behaviour [3] and in the design of new materials [4].
Recently, we have shown that mono and dinuclear arene
ruthenium complexes containing 2,2 0-bipyrimidine as
terminal or bridging chelate ligand catalyse the transfer
hydrogenation of acetophenone with formic acid in
aqueous solution to give phenylethanol and carbon
dioxide [5].* Corresponding authors. Tel.: +41 032 7182499; fax: +41 032 7182511.
E-mail address: bruno.therrien@unine.ch (B. Therrien).R
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Interestingly, an increase of the catalytic activity by
three to ﬁve times in going from the mononuclear to
the dinuclear complexes was observed. The higher cata-
lytic activity of the dinuclear arene ruthenium complexes
was accounted for by a synergistic electronic eﬀect in the
intact dinuclear moieties. The molecular structures of
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2various dinuclear arene ruthenium and osmium com
plexes containing 2,2 0-bipyrimidine as bridging chelat
ligand have shown that the two chloro ligands can b
found in both cis and trans orientations [6]. Therefore
in order to determine if the increase in the catalytic activ
ity is correlated to the cis–trans conformations, we pre
pared a series of exclusively trans oriented dinuclea
arene ruthenium complexes with the sterically hindere
chelate ligand, 6,7-dimethyl-2,3-di(pyridine-2-yl)quinoxa
line (dpqMe2). The catalytic activity of the dinuclea
complexes and of their corresponding mononuclear cong
eners for the transfer hydrogenation of aromatic ketone
to give the corresponding secondary alcohol with sodium
formate as the hydrogen donor in aqueous solution
reported. We also present the single-crystal X-ray struc
ture analysis of some representatives.
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-2. Results and discussion
2.1. Synthesis of the mononuclear complexes 1–4 as
hexaﬂuorophosphate salts
The arene ruthenium complexes [(g6-arene)Ru(l-Cl)Cl
(arene = C6H6, C6H5Me, p-Pr
iC6H4Me, C6Me6) react wit
2 equiv. of 6,7-dimethyl-2,3-di(pyridine-2-yl)quinoxalin
(dpqMe2) in methanol at 50 C in the presence of KPF
to form the cationic arene ruthenium complexes [(g6
C6H6)RuCl(dpqMe2)]
+ (1), [(g6-C6H5Me)RuCl(dpqMe2)]
(2), [(g6-p-PriC6H4Me)RuCl(dpqMe2)]
+ (3) and [(g6
C6Me6)RuCl(dpqMe2)]
+ (4), which are isolated as the
hexaﬂuorophosphate salts (Scheme 1). The hexaﬂuoro
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Scheme 1. Synthesis of cations 1–4.phosphate salts of complexes 1–4 are red-purple, non
hygroscopic, air-stable, crystalline solids. They ar
sparingly soluble in methanol and chloroform, but well so
uble in dichloromethane, acetone and acetonitrile. All com
pounds have been characterised on the basis of elementa
analysis, 1H NMR, IR, UV–Vis and mass spectroscopy.
In the mass spectra they give rise to the correspondin
[M]+ molecular peaks m/z at 527, 541, 583 and 611, respec
tively. The 1H NMR spectra of 1–4 exhibit, other than th
signals corresponding to the aromatic ligand, a characteris
tic set of 12 independent signals for the diastereotopic pro
tons of the dpqMe2 ligand. The ruthenium atom
stereogenic due to the coordination of four diﬀerent ligato
atoms. Upon coordination to the ruthenium atom, the aro
matic protons of the dpqMe2 ligand are shifted downﬁeld
especially the Ha of the coordinated pyridyl group which
observed at d  9.4 ppm, while the Ha0 of the non-coord
nated pyridyl group is observed at only 8.65 ppm. Accord
ingly, the aromatic protons of the quinoxaline moiety ar
observed at d  8.6 (Hq) and 8.1 ðHq0 Þ, respectively. Th
1H NMR spectrum of 3 exhibits two doublets for the dia
stereotopic methyl protons of the isopropyl group. Like
wise, the diastereotopic CH protons of the p-cymen
ligand give rise to four doublets observed betwee
d = 5.7–6.1 ppm. A septet at d = 2.51 ppm is observed fo
the CH proton of the isopropyl group. Similarly, the aro
matic protons of the toluene ligand in 2 give rise to ﬁv
multiplets observed between d = 5.7–6.2 ppm and a single
at d = 2.36 ppm for the methyl group.
The UV–Vis data of complexes 1–4 have been recorde
in acetonitrile. The electronic spectra display a medium
intensity band in the visible region at 385 nm and a
intense band at 280 nm. The low intensity band a
385 nm is assigned to the metal-to-ligand charge transfe
transition (MLCT), while the high-energy band a
280 nm is assigned to intra-ligand p–p* transitions [7].
2.2. Synthesis of the dinuclear complexes 5–8 as
hexaﬂuorophosphate salts
The reaction of the dimeric chloro complexes [(g6-are
ne)Ru(l-Cl)Cl]2 (arene = C6H6, C6H5Me, p-Pr
iC6H4Me
C6Me6) with 1 equiv. of 6,7-dimethyl-2,3-di(pyridine
2-yl)quinoxaline (dpqMe2) in reﬂuxing methanol in th
presence of KPF6 results in the formation of the red-purpl
coloured, air-stable dinuclear complex dications [{(g6
C6H6)RuCl}2(l-dpqMe2)]
2+ (5), [{(g6-C6H5Me)RuCl}2
(l-dpqMe2)]
2+ (6), [{(g6-p-PriC6H4Me)RuCl}2(l-dpqMe2)]
2
(7) and [{(g6-C6Me6)RuCl}2(l-dpqMe2)]
2+ (8), which ca
be isolated as their hexaﬂuorophosphate salts (Scheme 2)
Complexes 5–8 have been characterised by mass, UV
Vis, 1H NMR spectroscopy and elemental analysis. I
the mass spectra the hexaﬂuorophosphate salts give ris
to two main peaks; a minor peak with an approximatel
50% intensity attributed to [M2++PF6
]+ at m/z 887
915, 999 and 1055, respectively, and a major peak whic
corresponds after decomplexation of an [(arene)RuCl]
Fig. 1. Molecular structure of 1 at 50% probability level with hydrogen
atoms, acetonitrile molecules and hexaﬂuorophosphate anion being
omitted for clarity.
Fig. 2. Molecular structure of 3 at 50% probability level with hydrogen
atoms, acetonitrile molecule and hexaﬂuorophosphate anion being
omitted for clarity.
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Scheme 2. Synthesis of the dications 5–8.
3fragment to the mononuclear cations 1–4 at m/z = 527,
541, 583 and 611, respectively. The UV–Vis data of com-
plexes 5–8 in acetonitrile show that the position of the
MLCT transitions of the dinuclear complexes 5–8 is signif-
icantly red shifted (490 nm) as compared to their mono-
nuclear congeners.
The 1H NMR spectra of 5–8 exhibit, other than the sig-
nals corresponding to the aromatic ligand, a characteristic
set of six signals for the protons of the dpqMe2 ligand.
Despite the fact that the two ruthenium atoms are stereo-
genic and therefore should generate a mixture of rac and
meso diastereoisomers, only the rac isomer is observed.
The sterically hindered dpqMe2 ligand forces the chloro
ligands to adopt exclusively a trans orientation, thus giving
rise to only the (R,R) and (S,S) enantiomers and conse-
quently six signals for the dpqMe2 bridging ligand. As
observed in 1–4, the aromatic protons of the dpqMe2
ligand are shifted downﬁeld, especially the Ha of the pyr-
idyl groups which are observed at d  9.4 ppm, while the
aromatic protons of the quinoxaline moiety are observed
at d  8.7 ppm.
2.3. Crystal structure analysis of [(g6-
C6H6)RuCl(dpqMe2)][PF6] ([1][PF6]),
[(g6-p-PriC6H4Me)RuCl(dpqMe2)][PF6] ([3][PF6])
and [(g6-C6H5Me)RuCl(l-dpqMe2)][PF6]2 ([6][PF6]2)
The molecular structures of [(g6-C6H6)RuCl(dpqMe2)]
+
(1) and [(g6-p-PriC6H4Me)RuCl(dpqMe2)]
+ (3) have been
established by single-crystal X-ray structure analysis of
their hexaﬂuorophosphate salts. Both complexes show a
typical piano-stool geometry with the metal centres coordi-
nated by the arene ligand, a terminal chloride and the che-
lating dpqMe2 ligand. The molecular structures of [1][PF6]
and [3][PF6] are presented in Figs. 1 and 2, respectively,
while selected geometrical parameters are presented in
Table 1.
In the mononuclear complexes 1 and 3, the metal centre
is stereogenic. However, since none of the ligand contains a
chiral information, 1 and 3 are obtained as racemic mix-
tures and crystallised in the centrosymmetric space group
C2/c and P21/n, respectively.The Ru–N bond distances ranging from 2.057(3) to
2.118(2) A˚ in 1 and 3 are comparable to those in [(g6-p-
PriC6H4Me)RuCl(2,3-bis(2-pyridyl)pyrazine)][BF4] [8] and
[(g6-p-PriC6H4Me)RuCl(2,3-bis(a-pyridyl)quinoxaline)]
[PF6] [9a]. Accordingly, there is no signiﬁcant diﬀerence in
the Ru–Cl bond length in 1 or 3 [2.389(1) and 2.3878(9) A˚]
and reported values [9–11]. The N(1)–Ru(1)–N(2) bond
angle in complexes 1 [76.04(15)] and 3 [76.33(10)] are sim-
ilar to those of complexes [(g6-p-PriC6H4Me)RuCl(2,3-
bis(2-pyridyl)pyrazine)]+ [N(1)–Ru(1)–N(2) = 76.5(2)] [8]
and [(g6-p-PriC6H4Me)RuCl(2,3-bis(a-pyridyl)quinoxa-
line)]+ [N(1)–Ru(1)–N(2) = 76.2(2)] [9a].
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Fig. 4. Molecular structure of 6 at 50% probability level with hydrogen
atoms, acetonitrile molecules and hexaﬂuorophosphate anions being
omitted for clarity.
Table 1
Selected bond lengths (A˚) and angles () for [1][PF6], [3][PF6] and [6][PF6]2
[1][PF6] [3][PF6] [6][PF6]2
Ru1 Ru2
Interatomic distances
Ru1–N1 (Ru2–N3) 2.067(4) 2.057(3) 2.083(6) 2.109(5)
Ru1–N2 (Ru2–N4) 2.108(4) 2.118(2) 2.115(6) 2.063(6)
Ru1–Cl1 (Ru2–Cl2) 2.389(1) 2.3878(9) 2.393(2) 2.384(2)
Ru–centroid (arene) 1.692 1.694 1.698 1.695
C5–C6 1.472(6) 1.466(4) 1.482(9)
C7–C8 1.509(7) 1.467(5) 1.473(10)
Angles and torsion angles
N1–Ru1–N2 (N3–Ru2–
N4)
76.04(15) 76.33(10) 76.3(2) 76.4(2)
N1–Ru1–Cl1 (N3–Ru2–
Cl2)
85.93(11) 86.08(7) 85.51(19) 88.48(17)
N2–Ru1–Cl1 (N4–Ru2–
Cl2)
85.55(10) 88.27(7) 88.47(18) 86.29(19)
N1–C5–C6–N2 11.2(6) 14.7(4) 16.5(9)
N3–C7–C8–N4 131.8(5) 131.2(3) 12.5(10)
C5–C6–C7–C8 23.1(8) 18.3(4) 32.9(12)
4In the crystal packing of [1][PF6] Æ 2CH3CN, two mole
cules of 1 form a dimer through p-stacking interaction
see Fig. 3. The centroid–centroid separations are 3.73 an
4.32 A˚. The distance observed between the p–p interactin
systems is in accordance with the theoretical value calcu
lated for this stacking mode [10].
Cation 6 crystallises in the space group P-1 with bot
enantiomers R,R-6 and S,S-6 being present in the crysta
As mentioned earlier, the sterically hindered dpqMe
ligand forces the chloro atoms to adopt a trans orientation
thus generating only the rac isomers. An ORTEP drawin
with the atom labelling scheme for 6 is shown in Fig. 4 an
the selected geometrical parameters are presented in Tabl
1. As expected, cation 6 contains two metal centres bonde
to g6-C6H5Me and chloro ligands and bridged by
dpqMe2 ligand through its nitrogen atoms. The distancd
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isFig. 3. Dimeric structure of 1 showing the intermolecular p-stacking
interactions.between the ruthenium atoms is 6.96 A˚, which is in accor
dance with the metal–metal distances observed in th
homo-bimetallic complex [(g6-p-PriC6H4Me)2Ru2Cl2
(l-2,3-di(pyridine-2-yl)pyrazine)][PF6]2 (Ru–Ru distance =
6.84 A˚) [9b] and in the hetero-bimetallic dpqMe2 comple
[(bipy)2Ru(l-dpqMe2)Cu(PPh3)2][BF4]3 (bipy = 2,20-bipyr
dine) (Ru–Cu distance = 6.82 A˚) [11].
Upon formation of mono or dinuclear complexes, th
bond lengths between the connecting carbon atom
between the pyridyl and the quinoxaline moieties of th
dpqMe2 ligand are slightly reduced. Indeed, as compare
to the free 6,7-dimethyl-2,3-di(pyridine-2-yl)quinoxalin
in which the C–C distances (C5–C6 and C7–C8) are bot
at 1.493 A˚ [12], the corresponding C–C distances in th
mononuclear complexes 1 and 3 are 1.472(6) an
1.466(4) A˚, respectively, while in the dinuclear complex
the distances are 1.473(10) and 1.482(9) A˚. These bon
length changes are in agreement with a back-donation from
the metallic fragments to the dpqMe2 system, thus increas
ing the inter-ring bond order [6,13].
The major distortion imposed on the dpqMe2 structur
upon coordination is encountered by the pyridyl group
see Fig. 5. In the free ligand the two pyridyl groups ar
twisted by 39.6 relative to the plane of the quinoxaline mo
ety. However, in 1 and 3 the twist of the coordinated pyridy
unit is 26.0(2) and 28.1(1), respectively, while the non-coor
dinated pyridyl unit remains at 41.7(1) and 41.1(1), respec
tively. Finally, the twist imposed on the pyridyl rings
raised to a maximum at 28.8(3) and 29.4(3) in 6.
Table 2
Catalytic transfer hydrogenation of acetophenone using the mononuclear
[(g6-arene)RuCl(dpqMe2)]
+ (1–4) and dinuclear complexes [{(g6-arene)-
RuCl}2(l-dpqMe2)]
2+ (5–8) as catalysts and formate as hydrogen donor in
watera
Entry Catalyst (g6-arene)Ru Conversion %
(h)b
TOF
(h1)c
1 1 (C6H6)Ru <1 (15)
2 2 (C6H5Me)Ru <1 (15)
3 3 (p-PriC6H4Me)Ru <1 (15)
4 4 (C6Me6)Ru <1 (15)
5 5 {(C6H6)Ru}2 2 (15) 0.1
6 6 {(C6H5Me)Ru}2 5 (15) 0.3
7 7 {(p-PriC6H4Me)Ru}2 6 (16) 0.4
8 8 {(C6Me6)Ru}2 1 (15) 0.1
a Conditions: Reactions carried out at 50 C, at pH = 4, in 5 mL of
water, acetophenone (0.64 mmol), the ratio catalyst/substrate/formate
being 1:100:500.
b Determined by gas chromatography.
c TOF: turnover frequencies are expressed in mol of product/(mol of
Ru Æ h).
Fig. 5. Axial views of the free dpqMe2 ligand (top), the mononuclear
cation 3 (middle) and the dinuclear dication 6 (bottom). The quinoxaline
moiety points away and the arene ligands are omitted for clarity.
52.4. Catalytic evaluation of 1–8 for the transfer
hydrogenation of acetophenone in aqueous solution
Based on the pioneering study of Ogo et al. on the use of
2,2 0-bipyridine complexes [(g6-C6Me6)Ru(bipy)(OH2)]
+
[14] and [(g5-C5Me5)Ir(bipy)(OH2)]
+ [15] and on our previ-
ously reported results on arene ruthenium phenanthroline
(phen) complexes [(g6-arene)Ru(phen)(OH2)]
+ (arene =
C6H6, p-Pr
iC6H4Me, C6Me6)[16], the catalytic potential
of the 6,7-dimethyl-2,3-di(pyridine-2-yl)quinoxaline com-
plexes 1–8 was evaluated for the transfer hydrogenation
of acetophenone in water using formic acid as hydrogen
source (Table 2).
O OH
1 - 8
HCOOH CO2
All complexes were found to poorly catalyse the trans-
fer hydrogenation of acetophenone to give phenylethanol
in aqueous solution at pH 4, which corresponds to the
pKa of the formic acid (3.77). In the best cases (complexes
6 and 7, entries 6 and 7) the conversion of acetophenone
does not exceed 6% within 16 h. This means that, in com-
parison to the corresponding 2,2 0-bipyrimidine complexes
[5], the introduction of a sterically hindered ligand systemwhich forces the dinuclear complexes to adopt a trans
conﬁguration causes a pronounced drop in the catalytic
activity.
3. Experimental
3.1. General
6,7-Dimethyl-2,3-di(pyridine-2-yl)quinoxaline (dpqMe2)
and KPF6 were purchased from Aldrich and used as
received. [Ru(g6-arene)(l-Cl)Cl]2 (arene = C6H6, C6H5Me,
p-PriC6H4Me, C6Me6) were prepared according to pub-
lished methods [17]. The NMR spectra were recorded on
a Varian Gemini 200 MHz spectrometer using the residual
protonated solvent as internal standard. Infrared spectra
were recorded as KBr pellets on a Perkin–Elmer FTIR
1720-X spectrometer. UV–Vis absorption spectra were
recorded on an Uvikon 930 spectrophotometer. Microanal-
yses were performed by the Laboratory of Pharmaceutical
Chemistry, University of Geneva (Switzerland). Electro-
spray mass spectra were obtained in positive-ion mode with
an LCQ Finnigan mass spectrometer.
3.2. Preparation of the mononuclear complexes 1–4
3.2.1. [(g6-C6H6)RuCl(dpqMe2)][PF6] ([1][PF6])
In a typical experiment, [(g6-C6H6)Ru(l-Cl)Cl]2
(100 mg, 0.20 mmol) is dissolved in methanol (50 mL).
The resulting solution is added dropwise to a two-necked
ﬂask equipped with a reﬂux condenser and containing a
methanol solution (50 mL) of dpqMe2 (125 mg, 0.40 mmol)
and KPF6 (73.6 mg, 0.40 mmol). The mixture is heated to
50 C and stirred for 24 h. After cooling to room tempera-
ture, the volume is reduced and the product is precipitated
by addition of diethylether. The yellow-orange solid is ﬁl-
tered, washed with n-pentane and dried under vacuum to
give [(g6-C6H6)RuCl(dpqMe2)][PF6] (80 mg, 0.12 mmol,
yield 30%). 1H NMR (400 MHz, CD3CN): d (ppm) =
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69.40 (d, 1H, 3J = 7.8 Hz, Hpyr), 8.65 (d, 1H,
3J = 7.5 Hz
Hpyr), 8.63 (s, 1H, Hqnox), 8.11 (m, 2H, Hpyr), 8.08 (
1H, Hqnox), 7.77 (dd, 1H, Hpyr), 7.62 (m, 2H, Hpyr), 7.0
(d, 1H, 3J = 7.1 Hz, Hpyr), 6.13 (s, 6H, Har), 2.74 (s, 3H
Meqnox), 2.65 (s, 3H, Meqnox); IR (KBr, cm
1): 840
m(P–F); 558 m. UV–Vis (1.19 · 105 M, CH3CN): kma
386 nm (e = 2.07 · 104 M1 cm1), 274 nm (e = 3.78 · 10
M1 cm1). ESI-MS (m/z): 527 [M+]; Anal. Calc. fo
C26H22N4ClF6PRu: C, 46.47; H, 3.30; N, 8.34. Found: C
46.12; H, 3.69; N, 7.77%.
3.2.2. [(g6-C6H5Me)RuCl(dpqMe2)][PF6] ([2][PF6])
The compound is prepared by the same procedure a
described above for [1][PF6] using [(g
6-C6H5Me)Ru(l
Cl)Cl]2 (100 mg, 0.19 mmol), dpqMe2 (118.2 mg
0.38 mmol) and KPF6 (69.7 mg, 0.38 mmol) and aﬀordin
[(g6-C6H5Me)RuCl(dpqMe2)][PF6] (140 mg, 0.20 mmo
yield 54%). 1H NMR (400 MHz, CD3CN): d (ppm) =
9.32 (d, 1H, 3J = 7.1 Hz, Hpyr), 8.66 (d, 1H,
3J = 7.4 Hz
Hpyr), 8.55 (s, 1H, Hqnox), 8.13 (m, 2H, Hpyr), 8.08 (
1H, Hqnox), 7.77 (dd, 1H,
3J = 8.3 Hz, Hpyr), 7.61 (m
2H, Hpyr), 7.07 (d, 1H,
3J = 9.5 Hz, Hpyr), 6.16 (dd, 1H
Har), 5.99 (dd, 1H,
3J = 5.9 Hz, Har), 5.92 (d, 1H,
3J =
6.1 Hz, Har), 5.74 (d, 1 H, Har), 5.68 (dd, 1H,
3J = 5.
Hz, Har), 2.73 (s, 3H, Meqnox), 2.65 (s, 3H, Meqnox), 2.3
(s, 3H, Mear); IR (KBr, cm
1): 840s m(P–F); 558 m. UV
Vis (1.16 · 105 M, CH3CN): kmax 385 nm (e = 4.46 · 10
M1 cm1), 278 nm (e = 8.82 · 104 M1 cm1). ESI-M
(m/z): 541 [M+]; Anal. Calc. for C27H24N4ClF6PRu: C
47.27; H, 3.53; N, 8.17. Found: C, 47.00; H, 3.70; N, 8.19%
3.2.3. [(g6-p-PriC6H4Me)RuCl(dpqMe2)][PF6]
([3][PF6])
The compound is prepared by the same procedure a
described above for [1][PF6] using [(g
6-p-PriC6H4
Me)Ru(l-Cl)Cl]2 (100 mg, 0.16 mmol), dpqMe2 (102.0 mg
0.32 mmol) and KPF6 (60.1 mg, 0.32 mmol) and aﬀordin
[(g6-p-PriC6H4Me)RuCl(dpqMe2)][PF6] (150 mg, 0.2
mmol, yield 63%). 1H NMR (400 MHz, CD3CN):
(ppm) = 9.37 (d, 1H, 3J = 7.1 Hz, Hpyr), 8.69 (d, 1 H
3J = 6.5 Hz, Hpyr), 8.52 (s, 1H, Hqnox), 8.09 (m, 2H, Hpyr
8.06 (s, 1H, Hqnox), 7.70 (m, 2H, Hpyr), 7.60 (dd, 1H, Hpyr
7.00 (d, 1H, Hpyr), 6.09 (d, 1H,
3J = 6.9 Hz, Har), 5.85 (m
2H,Har), 5.72 (d, 1H,
3J = 6.6 Hz,Har), 2.73 (s, 3H,Meqnox
2.64 (s, 3H, Meqnox), 2.51 (sept, 1H,
3J = 6.9 Hz, CHarMe2
2.36 (s, 3H, Mear), 1.11 (d, 3H, CHarMe2), 1.04 (d, 3H
CHarMe2); IR (KBr, cm
1): 840 s m(P–F); 557 m. UV–V
(5.50 · 106 M, CH3CN): kmax 436 nm (e = 19695.8
M1 cm1), 387 nm (e = 8.53 · 104 M1 cm1), 278 nm
(e = 17.55 · 104 M1 cm1). ESI-MS (m/z): 583 [M+]; Ana
Calc. for C30H30N4ClF6PRu: C, 49.49; H, 4.15; N, 7.70
Found: C, 49.17; H, 4.66; N, 7.47%.
3.2.4. [(g6-C6Me6)RuCl(dpqMe2)][PF6] ([4][PF6])
The compound is prepared by the same procedure a
described above for [1][PF6] using [(g
6-C6Me6)Ru(l-Cl)Cl
(100 mg, 0.15 mmol), dpqMe2 (93.4 mg, 0.30 mmol) anKPF6 (55.1 mg, 0.30 mmol) and aﬀording [(g
6-C6Me6)R
uCl(dpqMe2)][PF6] (145 mg, 0.20 mmol, yield 64%).
1H
NMR (400 MHz, CD3CN): d (ppm) = 8.77 (d, 1H
3J = 7.7 Hz, Hpyr), 8.65 (d, 1 H,
3J = 7.4 Hz, Hpyr), 8.2
(s, 1H, Hqnox), 8.17 (m, 2H, Hpyr), 8.05 (s, 1H, Hqnox
7.75 (dd, 1H, Hpyr), 7.60 (m, 2H, Hpyr), 7.07 (d, 1H
3J = 7.5 Hz, Hpyr), 2.67 (s, 3H, Meqnox), 2.62 (s, 3H
Meqnox), 2.20 (s, 18H, Mear); IR (KBr, cm
1): 843
m(P–F); 558 m. UV–Vis (1.06 · 105 M, CH3CN): kma
377 nm (e = 3.15 · 104 M1 cm1), 281 nm (e = 7.89
104 M1 cm1). ESI-MS (m/z): 611 [M+]; Anal. Calc. fo
C32H34N4ClF6PRu: C, 50.83; H, 4.53; N, 7.41. Found: C
50.94; H, 4.62; N, 7.42%.
3.3. Preparation of the dinuclear complexes 5–8
3.3.1. [{(g6-C6H6)RuCl}2(l-dpqMe2)][PF6]2
([5][PF6]2)
In a typical experiment, [(g6-C6H6)Ru(l-Cl)Cl
(150 mg, 0.30 mmol), dpqMe2 (93.6 mg, 0.30 mmol) an
KPF6 (110.0 mg, 0.60 mmol) are dissolved in methano
(30 mL). The resulting solution is heated to 60 C and stir
red for 4 h. After cooling to room temperature, the volum
is reduced and the product is precipitated by addition o
diethylether. The red solid is ﬁltered, washed with n-pen
tane and dried under vacuum to give [{(g6-C6H6
RuCl}2(l- dpqMe2)][PF6]2 (150 mg, 0.14 mmol, yiel
48%). 1H NMR (400 MHz, CD3CN): d (ppm) = 9.43 (d
2H, 3J = 6.4 Hz, Hpyr), 8.69 (s, 2H, Hqnox), 8.56 (d, 2H
3J = 8.2 Hz, Hpyr), 8.08 (dd, 2H,
3J = 7.8 Hz, Hpyr), 7.8
(dd, 2H, 3J = 6.9 Hz, Hpyr), 6.15 (s, 12H, Har), 2.80 (
6H, Meqnox); IR (KBr, cm
1): 840 s m(P–F); 559 m. UV
Vis (6.20 · 105 M, CH3CN): kmax 486 nm (e = 0.53 · 10
M1 cm1), 330 nm (e = 2.25 · 104 M1 cm1). ESI-M
(m/z): 887 [M+PF6]
+; 527 [M{(g6-C6H6)RuCl}]+; Ana
Calc. for C32H28N4Cl2F12P2Ru2: C, 37.26; H, 2.74; N
5.43. Found: C, 36.98; H, 3.23; N, 5.51%.
3.3.2. [{(g6-C6H5Me)RuCl}2(l-dpqMe2)][PF6]2
([6][PF6]2)
The compound is prepared by the same procedure a
described above for [5][PF6]2 using [(g
6-C6H5Me)Ru(l
Cl)Cl]2 (530 mg, 0.1 mol), dpqMe2 (312 mg, 0.1 mol) an
KPF6 (368 mg, 0.2 mol) and aﬀording [{(g
6-C6H5Me)R
uCl}2(l- dpqMe2)][PF6]2 (990 mg, 0.09 mol, yield 94%
1H NMR (400 MHz, CD3CN): d (ppm) = 9.34 (d, 2H
3J = 5.5 Hz, Hpyr), 8.57 (s, 2H, Hqnox), 8.52 (d, 2H,
3J =
8.1 Hz, Hpyr), 8.07 (dd, 2H,
3J = 6.6 Hz, Hpyr), 7.80 (dd
2H, 3J = 6.6 Hz, Hpyr), 6.20 (dd, 2H,
3J = 5.9 Hz, Har
5.94 (m, 4H, Har), 5.77 (d, 2H,
3J = 5.9 Hz, Har), 5.6
(dd, 2H, Har), 2.76 (s, 6H, Meqnox), 2.45 (s, 6H, Har); IR
(KBr, cm1): 843 s m(P–F); 558 m. UV–V
(3.77 · 106 M, CH3CN): kmax 492 nm (e = 0.95 · 10
M1 cm1), 327 nm (e = 4.43 · 104 M1 cm1). ESI-M
(m/z): 915 [M+PF6]
+; 541 [M{(g6-C6H6)RuCl}]+; Ana
Calc. for C34H32N4Cl2F12P2Ru2: C, 38.54; H, 3.04; N
5.29. Found: C, 38.21; H, 2.94; N, 5.11%.
73.3.3. [{(g6-p-PriC6H4Me)RuCl}2(l-dpqMe2)][PF6]2
([7][PF6]2)
The compound is prepared by the same procedure as
described above for [5][PF6]2 using [(g
6-p-PriC6H4-
Me)Ru(l-Cl)Cl]2 (200 mg, 0.33 mmol), dpqMe2 (76.5 mg,
0.33 mmol) and KPF6 (90.2 mg, 0.66 mmol) and aﬀording
[{(g6-p-PriC6H4Me)RuCl}2(l-dpqMe2)][PF6]2 (270 mg,
0.24 mmol, yield 72%). 1H NMR (400 MHz, CD3CN): d
(ppm) = 9.38 (d, 2H, 3J = 7.7 Hz, Hpyr), 8.59 (s, 2H,
Hqnox), 8.39 (d, 2H,
3J = 8.1 Hz, Hpyr), 8.10 (dd, 2H,
3J = 7.7 Hz, Hpyr), 7.84 (dd, 2H,
3J = 6.9 Hz, Hpyr), 6.10
(d, 4H, Har), 5.81 (d, 4H,
3J = 6.3 Hz, Har), 2.78 (s, 6H,
Meqnox), 2.73 (sept, 2H,
3J = 6.9 Hz, CHarMe2), 1.41 (s,
6H, Mear), 1.13 (d, 6H, CHarMe2), 0.87 (d, 6H, CHarMe2);
IR (KBr, cm1): 842 s m(P–F); 558 m. UV–Vis (7.35 · 105
M, CH3CN): kmax 508 nm (e = 0.43 · 104 M1 cm1),
327 nm (e = 1.68 · 104 M1 cm1). ESI-MS (m/z): 999
[M+PF6]
+; 583 [M{(g6-p-PriC6H4Me)RuCl}]+; Anal.
Calc. for C40H44N4Cl2F12P2Ru2: C, 42.00; H, 3.88; N,
4.90. Found: C, 39.95; H, 3.79; N, 4.60%.3.3.4. [{(g6-C6Me6)RuCl}2(l-dpqMe2)][PF6]2
([8][PF6]2)
The compound is prepared by the same procedure as
described above for [5][PF6]2 using [(g
6-C6Me6)Ru(l-
Cl)Cl]2 (200 mg, 0.30 mmol), dpqMe2 (93.4 mg, 0.30 mmol)
and KPF6 (110 mg, 0.60 mmol) and aﬀording [{(g
6-
C6Me6)RuCl}2(l-dpqMe2)][PF6]2 (145 mg, 0.12 mmol,Table 3
Crystallographic and selected experimental data for [1][PF6] Æ 2CH3CN, [3][PF
[1][PF6] Æ 2CH3CN
Chemical formula C30H28ClF6N6PRu
Formula weight 754.07
Crystal system monoclinic
Space group C2/c (no. 15)
Crystal colour and shape red rod
Crystal size 0.2 · 0.2 · 0.1
a (A˚) 34.208(4)
b (A˚) 7.4461(5)
c (A˚) 29.870(3)
a ()
b () 124.652(6)
c ()
V (A˚3) 6258.9(10)
Z 8
T (K) 173(2)
Dcalc (g cm
3) 1.601
l (mm1) 0.705
Scan range () 1.45 < h < 25.17
Unique reﬂections 5558
Observed reﬂections [I > 2r(I)] 4125
Rint 0.0985
Final R indices [I > 2r(I)]a 0.0549, wR2 0.1427
R indices (all data) 0.0690, wR2 0.1477
Goodness-of-ﬁt 0.948
Maximum, minimum Dq (e A˚3) 1.465, 1.279
a Structures were reﬁned on F2o: wR2 = [
P
[w(F2o  F2c)2]/
P
w(F2o)
2]1/2, whereyield 40%). 1H NMR (400 MHz, CD3CN): d (ppm) =
8.77 (d, 2H, 3J = 7.9 Hz, Hpyr), 8.65 (d, 2H,
3J = 7.5 Hz,
Hpyr), 8.05 (s, 2H, Hqnox), 7.75 (dd, 2H,
3J = 8.3 Hz, Hpyr),
7.64 (dd, 2H, 3J = 7.6 Hz, Hpyr), 3.29 (s, 6H, Meqnox), 2.63
(s, 18H, Mear); IR (KBr, cm
1): 844 s m(P–F); 558 m. UV–
Vis (5.30 · 105 M, CH3CN): kmax 551 nm (e = 0.58 ·
104 M1 cm-1), 403 nm (e = 1.49 · 104 M1 cm1), 328 nm
(e = 2.45 · 104 M1 cm1). ESI-MS (m/z): 1055 [M+
PF6]
+; 611 [M{(g6-p-PriC6H4Me)RuCl}]+; Anal. Calc.
for C44H52N4Cl2F12P2Ru2: C, 44.04; H, 4.37; N, 4.67.
Found: C, 42.29; H, 4.60; N, 4.26%.
3.4. Single-crystal X-ray structure analyses
Crystals of complexes [1][PF6] Æ 2CH3CN, [3][PF6] Æ
CH3CN and [6][PF6]2 Æ 2CH3CN were mounted on a Stoe
Image Plate Diﬀraction system equipped with a / circle
goniometer, using Mo Ka graphite monochromated radi-
ation (k = 0.71073 A˚) with / range 0–200. The struc-
tures were solved by direct methods using the program
SHELXS-97 [18]. Reﬁnement and all further calculations
were carried out using SHELXL-97 [18]. The H-atoms were
included in calculated positions and treated as riding
atoms using the SHELXL default parameters. The non-H
atoms were reﬁned anisotropically, using weighted full-
matrix least-squares on F2. Crystallographic details are
summarised in Table 3. Figs. 1, 2 and 4 were drawn
with ORTEP [19] and Figs. 3 and 5 with the software
MERCURY [20].6] Æ CH3CN and [6][PF6]2 Æ 2CH3CN
[3][PF6] Æ CH3CN [6][PF6]2 Æ 2CH3CN
C32H33ClF6N5PRu C38H38Cl2F12N6P2Ru2
769.12 1141.72
monoclinic triclinic
P21/n (no. 14) P1 (no. 2)
red block red block
0.3 · 0.3 · 0.15 0.4 · 0.4 · 0.2
14.450(3) 13.003(1)
8.370(2) 13.340(1)
27.320(5) 14.516(2)
111.43(1)
97.16(3) 106.64(1)
100.00(1)
3278.5(12) 2133.8(4)
4 2
173(2) 173(2)
1.558 1.777
0.674 0.998
2.55 < 2h < 26.15 2.42 < 2h < 25.97
6176 7760
4407 4876
0.0358 0.1736
0.0341, wR2 0.0776 0.0603, wR2 0.1597
0.0532, wR2 0.0822 0.0976, wR2 0.2007
0.897 1.022
0.473, 1.484 1.315, 1.755
w1 = [
P
(F2o) + (aP)
2 + bP] and P = [max(F2o,0) + 2F
2
c]/3.
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83.5. Transfer hydrogenation catalysis
The transfer hydrogenation reactions of acetophenon
(0.64 mmol) using 1–8 as their hexaﬂuorophosphate salt
(6.4 lmol) with formate (3.2 mmol) are carried out in wate
(5 mL) using a buﬀer of HCOOH/HCOONa at pH 4 unde
inert atmosphere. The reaction is quenched by cooling th
mixture to 0 C. The products are extracted by Et2O an
identiﬁed (and turnover determined) by gas chromatogra
phy. The pH is monitored using a pH meter (Mettle
Toledo InLab 413).
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Appendix A. Supplementary material
CCDC 641057, 641058 and 641059 contain the supple
mentary crystallographic data for [1][PF6] Æ 2CH3CN
[3][PF6] Æ CH3CN and [6][PF6]2 Æ 2CH3CN. These data ca
be obtained free of charge via http://www.ccdc.cam.ac
uk/conts/retrieving.html, or from the Cambridge Crysta
lographic Data Centre, 12 Union Road, Cambridge CB
1EZ, UK; fax: (+44) 1223-336-033; or e-mail: depos
it@ccdc.cam.ac.uk. Supplementary data associated wit
this article can be found, in the online version, a
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